V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/10888615

Download in:

View as

General Info

PMID
10888615